At the JPMorgan Healthcare Conference, drugmakers are expected to roll out key business and drug pipeline updates and splashy M&A deals.
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions.
Next week, I’ll be attending the annual JPMorgan Healthcare Con… [3566 chars]
Source: CNBC | Published: 2026-01-09T17:57:01Z
Credit: CNBC
